Will cartridge-based CBC systems replace central labs? Henry Schein bets on it with CitoCBC
Find out how Henry Schein’s exclusive U.S. deal for CytoChip’s CLIA-waived CitoCBC could reshape point-of-care blood diagnostics.
What EndoQuest’s PARADIGM Trial approval reveals about robotic ESD innovation in GI surgery
EndoQuest wins FDA approval to complete PARADIGM Trial for its ELS system. Find out what this milestone means for robotic GI surgery innovation.
Why Provation’s iPro Lite could signal the end of paper-based anesthesia workflows
Provation launches iPro Lite for mobile anesthesia documentation. Find out how it could change billing, compliance, and risk in outpatient surgery centers.
Can wearable ultrasound reinvent breast imaging? What the iSono Health ATUSA launch really signals
iSono Health launches ATUSA™, the first wearable breast ultrasound. Find out how it could transform access, accuracy, and economics in breast imaging.
FDA clears BEAR Implant label for lower osteoarthritis risk: What this changes in ACL surgery
FDA clears PTOA risk reduction claim for Miach Orthopaedics’ BEAR Implant. Find out what this means for ACL treatment, patients, and future adoption.
FDA clears VizMark’s VM1 tumor marker: Is this the fix for MRI artifact in breast imaging?
VizMark’s VM1 marker receives FDA clearance for artifact-free breast imaging. Find out how this may change tumor localization in dense breast cases.
What FDA breakthrough status for the Amplifi Vein Dilation System means for dialysis care in 2026
Amplifi Vascular’s device earns FDA Breakthrough and CMS Category B status. Find out what this means for dialysis access innovation and payer alignment.
Strive finalizes Semler Scientific acquisition to strengthen diagnostic and patient monitoring capabilities
Find out how Strive’s acquisition of Semler Scientific strengthens its diagnostic and patient monitoring capabilities in the regulated medical device market.
Why AIROS Medical’s extended warranty could reshape buyer expectations in lymphedema care
Find out how AIROS Medical’s five-year warranty on compression devices may shift durability standards and procurement expectations in lymphedema care.
GT Medical Technologies’ BRIDGES trial begins enrollment, testing GammaTile in newly diagnosed glioblastoma patients
GT Medical Technologies has announced the first patient enrollments in its BRIDGES trial, a randomized clinical study assessing the use of GammaTile therapy in newly diagnosed glioblastoma. The trial introduces GammaTile at the time of initial tumor resection, marking a notable shift from the conventional glioblastoma radiation timeline, which typically delays radiation until several weeks […]